Polatuzumab Vedotin in Patients With Relapsed and Refractory Diffuse Large B Cell Lymphoma
Clinical trial NCT05006534 · COMPLETED
Trial details
- NCT number
- NCT05006534
- Sponsor
- National Taiwan University Hospital
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-06-01
- Primary completion
- 2021-06-29
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.